Blockade of p38α MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 338-351

  Stambe, Cosimo ^a   Atkins, Robert C ^a,b   Tesch, Greg H ^a,b   Kapoun, Ann M ^c,d   Hill, Prudence A ^c,d   Schreiner, George F ^c,d   Nikolic Paterson, David J ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SCIOS INC   (United States)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PADGEM PROTEIN; ACTIVATING TRANSCRIPTION FACTOR 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME INHIBITOR; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; INFLAMMATORY DISEASE; KIDNEY BIOPSY; KIDNEY INJURY; NEUTROPHIL; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GLOMERULUS; INFECTION; METABOLISM; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; THROMBOCYTE; URINE; VASCULAR ENDOTHELIUM;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BLOOD PLATELETS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GLOMERULONEPHRITIS; HUMANS; INFECTION; ISOENZYMES; KIDNEY GLOMERULUS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHIL INFILTRATION; P-SELECTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS;

EID: 0037307476     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000048715.12315.FD     Document Type: Article

References (47)

1. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al.: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994
2. Ono K, Han J: The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13, 2000
3. Waas WF, Lo HH, Dalby KN: The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways. J Biol Chem 276: 5676-5684, 2001
4. Heine H, Ulmer AJ, Flad HD, Hauschildt S: Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J Immunol 155: 4899-4908, 1995
5. Rawadi G, Ramez V, Lemercier B, Roman-Roman S: Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: Involvement in cytokine synthesis. J Immunol 160: 1330-1339, 1998
6. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995
7. Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD: Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 284: 687-692, 1998
8. Badger AM, Griswold DE, Kapadia R, Blake S, Swift BA, Hoffman SJ, Stroup GB, Webb E, Rieman DJ, Gowen M, Boehm JC, Adams JL, Lee JC: Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 43: 175-183, 2000
9. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Suratt BT, Janes MS, Henson PM, Worthen GS: Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164: 2151-2159, 2000
10. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 29: 628-634, 2001
11. Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE: SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 279: L895-902, 2000
12. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40: 425-433, 1991
13. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC: A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 43: 97-102, 1995
14. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000
15. Gibson UE, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001, 1996
16. Naish PF, Thomson NM, Simpson IJ, Peters DK: The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol 22: 102-111, 1975
17. Takazoe K, Tesch GH, Hill PA, Hurst LA, Jun Z, Lan HY, Atkins RC, Nikolic-Paterson DJ: CD44-mediated neutrophil apoptosis in the rat. Kidney Int 58: 1920-1930, 2000
18. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B: PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59: 305-312, 1989
19. Segawa C, Wada T, Takaeda M, Furuichi K, Matsuda I, Hisada Y, Ohta S, Takasawa K, Takeda S, Kobayashi K, Yokoyama H: In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int 52: 1054-1063, 1997
20. Mulligan MS, Johnson KJ, Todd RF 3rd, Issekutz TB, Miyasaka M, Tamatani T, Smith CW, Anderson DC, Ward PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91: 577-587, 1993
21. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7: 2271-2278, 1996
22. Wysk M, Yang DD, Lu HT, Flavell RA, Davis RJ: Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc Natl Acad Sci USA 96: 3763-3768, 1999
23. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR: Interleukin-1 beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 273: 28670-28676, 1998
24. Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ: Different activation of mitogen-activated protein kinases in experimental proliferative glomerulonephritis. Kidney Int Suppl 67: S189-S191, 1998
25. Wada T, Furuichi K, Sakai N, Hisada Y, Kobayashi K, Mukaida N, Tomosugi N, Matsushima K, Yokoyama H: Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 38: 1169-1177, 2001
26. Dunlop ME, Muggli EE: Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int 57: 464-475, 2000
27. Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC: An osmosensing signal transduction pathway in yeast. Science 259: 1760-1763, 1993
28. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994
29. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148, 1993
30. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994
31. Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393, 1995
32. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255, 1996
33. Johnson RJ, Klebanoff SJ, Couser WG: Cellular mediators of immune injuries: Neutrophils. In: Immunologic Renal Diseases, 2nd edition, edited by Neilson EG, Couser WG, 2001, pp 579-592
34. Nahas N, Molski TF, Fernandez GA, Sha'afi RI: Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J 318: 247-253, 1996
35. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, Billstrom MA, Henson PM, Johnson GL, Worthen GS: Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103: 851-858, 1999
36. Zu YL, Qi J, Gilchrist A, Fernandez GA, Vazquez-Abad D, Kreutzer DL, Huang CK, Sha'afi RI: p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 160: 1982-1989, 1998
37. Forsberg M, Lofgren R, Zheng L, Stendahl O: Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils. Immunology 103: 465-472, 2001
38. Mocsai A, Jakus Z, Vantus T, Berton G, Lowell CA, Ligeti E: Kinase pathways in chemoattractant-induced degranulation of neutrophils: The role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 164: 4321-4331, 2000
39. Zachem CR, Alpers CE, Way W, Shankland SJ, Couser WG, Johnson RJ: A role for P-selectin in neutrophil and platelet infiltration in immune complex glomerulonephritis. J Am Soc Nephrol 8: 1838-1844, 1997
40. Tipping PG, Huang XR, Berndt MC, Holdsworth SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 46: 79-88, 1994
41. Ito I, Yuzawa Y, Mizuno M, Nishikawa K, Tashita A, Jomori T, Hotta N, Matsuo S: Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis. Am J Kidney Dis 38: 265-273, 2001
42. De Vriese AS, Endlich K, Elger M, Lameire NH, Atkins RC, Lan HY, Rupin A, Kriz W, Steinhausen MW: The role of selectins in glomerular leukocyte recruitment in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 10: 2510-2517, 1999
43. Mayadas TN, Mendrick DL, Brady HR, Tang T, Papayianni A, Assmann KJ, Wagner DD, Hynes RO, Cotran RS: Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int 49: 1342-1349, 1996
44. Rosenkranz AR, Mendrick DL, Cotran RS, Mayadas TN: P-selectin deficiency exacerbates experimental glomerulonephritis: A protective role for endothelial P-selectin in inflammation. J Clin Invest 103: 649-659, 1999
45. Gamble JR, Skinner MP, Berndt MC, Vadas MA: Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMPI40. Science 249: 414-417, 1990
46. Reimold AM, Kim J, Finberg R, Glimcher LH: Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. Int Immunol 13: 241-248, 2001
47. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, Barone FC, Ma XL: p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 53: 414-422, 2002